Department: Institute of Population Health Sciences
Salary: £34,220 - £40,194 per annum (Grade 4)
Date posted: 11-May-2020
Closing date: 07-Jun-2020
Institute of Population Health Sciences
Centre for Clinical Trials and Methodology
Pragmatic Clinical Trials Unit
Clinical Trials Monitor
£34,220 - £40,194 per annum
Ref : QMUL21631
Applications are invited for the role of Clinical Trials Monitor in the Pragmatic Clinical Trials Unit (PCTU) in the newly established Institute of Population Health Science. IPHS is a world class, multidisciplinary grouping of academics. Its focus is on population health sciences, spanning public and global health, health services research, health policy, genomics and data science, behavioral and social sciences. IPHS delivers evidence to implement health system change for population benefit.
The Institute comprises four centres; Centre for Primary Care and Mental Health, Centre for Clinical Trials and Methodology, Centre for Global Public Health and Centre for Women’s Health. The post will be based in the Centre for Clinical Trials and Methodology (CCTM).
We are looking for a Clinical Trials Monitor to join our thriving and dynamic clinical trials unit. The PCTU has particular expertise in pragmatic trials: trials of interventions as they would be delivered in practice. You will be joining a team of Quality Assurance Specialists and a Clinical Trials Monitor currently working within the unit on a wide variety of trials and observational studies.
The post holder’s primary role will be to conduct on-site Monitoring visits for the #ChariotMS Trial.
#ChariotMS is a multi-centre, randomised, double-blind, placebo-controlled, phase IIb trial. The aim of the trial is to test oral cladribine (Mavenclad®) compared to a placebo for safety, efficacy, and cost-effectiveness, and to advance mechanistic understanding in people with advanced Multiple Sclerosis (MS), i.e. disability severe enough to limit their ability to walk beyond a short distance with support, or not being able to walk at all, but with some retained upper limb function. #ChariotMS is the first ever disease modifying treatment (DMT) trial focussing on people with MS at this stage of disability.
Approximately 20 Investigator sites in the UK will be selected to participate in the trial. The post-holder’s main responsibility will be to monitor the conduct of the trial at participating sites to ensure compliance with Regulatory requirements, GCP guidelines and Sponsor and PCTU Procedures.
The post is a full time, fixed term appointment for 4 years starting in September 2020. Starting salary will be in the range of £34,220 - £40,194 per annum, inclusive of London Allowance. Benefits include 30 days annual leave, pension scheme and interest-free season ticket loan.
Candidates must be able to demonstrate their eligibility to work in the UK in accordance with the Immigration, Asylum and Nationality Act 2006. Where required this may include entry clearance or continued leave to remain under the Points Based Immigration Scheme.
Informal enquiries should be addressed to Kamela Aliaj at email@example.com.
Details about the Institute can be found at www.qmul.ac.uk/blizard/research/centres/institute-of-population-health-sciences.
To apply for the role, please click the ‘apply’ button below.
The closing date for applications is 07 June 2020. Interviews are expected to be held shortly thereafter.
The School of Medicine and Athena SWAN Charter for Women in Science.
The School of Medicine holds a Silver Athena SWAN Award. We are committed to the equality of opportunities and to advancing women’s careers. We have policies to support staff returning from long-term absence, for flexible arrangements for staff with parental responsibilities and for childcare support. As part of the School’s commitment to the Athena SWAN principles we strongly encourage applications from women.
Valuing Diversity & Committed to Equality